Satoh, T.;                     Trudler, D.;                     Oh, C.-K.;                     Lipton, S.A.    
        Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants 2022, 11, 124.
    https://doi.org/10.3390/antiox11010124
    AMA Style
    
                                Satoh T,                                 Trudler D,                                 Oh C-K,                                 Lipton SA.        
                Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants. 2022; 11(1):124.
        https://doi.org/10.3390/antiox11010124
    
    Chicago/Turabian Style
    
                                Satoh, Takumi,                                 Dorit Trudler,                                 Chang-Ki Oh,                                 and Stuart A. Lipton.        
                2022. "Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome" Antioxidants 11, no. 1: 124.
        https://doi.org/10.3390/antiox11010124
    
    APA Style
    
                                Satoh, T.,                                 Trudler, D.,                                 Oh, C.-K.,                                 & Lipton, S. A.        
        
        (2022). Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants, 11(1), 124.
        https://doi.org/10.3390/antiox11010124